Business Standard

Monday, December 23, 2024 | 04:22 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Covid: Case data, vaccine news mark small victories in Omicron battle

AstraZeneca, Novavax say their shots protect from Omicron * UK data suggests fewer hospitalisations than from Delta

Travellers wait for trains at the Moynihan Train Hall at Penn Station ahead of the Christmas holiday, in New York City (Photo: Reuters)
Premium

Travellers wait for trains at the Moynihan Train Hall at Penn Station ahead of the Christmas holiday, in New York City (Photo: Reuters)

Reuters
Travellers wait for trains at the Moynihan Train Hall at Penn Station ahead of the Christmas holiday, in New York City (Photo: Reuters)
Two vaccine makers said their shots protected against the Omicron coronavirus variant as UK data suggested it may cause proportionally fewer hospital cases than the Delta strain, though public health experts warned the battle against COVID-19 was far from over.

Similar encouraging evidence about hospitalisation rates had emerged from South Africa on Wednesday, but the head of Africa's main public health agency joined the World Health Organization in cautioning that it was too soon to draw broad conclusions

Disclaimer: No Business Standard Journalist was involved in creation of this content

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in